Biocompatibility issues of implanted polymeric materials

被引:0
作者
Satish, C. S. [1 ]
Kumar, Chetan [1 ]
Narasimhamurthy, S. [2 ]
Shivakumar, H. G. [2 ]
机构
[1] JSS Coll Pharm, Mysore 570015, Karnataka, India
[2] Univ Mississippi, Sch Pharm, University, MS 38677 USA
关键词
biocompatibility; polymers; biodegradable; blood compatibility; implant;
D O I
暂无
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Polymers remain the most versatile class of biomaterials, being extensively applied in medicine and biotechnology, as well as in the food and cosmetics industries. Applications include surgical devices, implants and supporting materials. The biocompatibility and immunocompatibility of polymeric materials is of fundamental importance for their possible therapeutic uses. Implanted systems are in direct and sustained contact with the tissues, and some of them degrade in situ. Thus, both the material itself and its degradation products must be devoid of toxicity. The knowledge and understanding of the criteria and mechanisms determining the biocompatibility of biomaterials are therefore of great importance. The biocompatibility of a polymer depends on the specific adsorption of proteins to the polymer surface and the subsequent cellular interactions. The first contact is between the surface of the polymer and the organism (blood and other tissues) and results in a 'foreign-body' reaction. Owing to the nature of these interactions, surface modification strategies have been used to optimize specific surface properties (e.g. charge, adhesion, hydrophilicity) of the implanted polymeric materials.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 62 条
  • [1] Molecularly engineered p(HEMA)-based hydrogels for implant biochip biocompatibility
    Abraham, S
    Brahim, S
    Ishihara, K
    Guiseppi-Elie, A
    [J]. BIOMATERIALS, 2005, 26 (23) : 4767 - 4778
  • [2] SURFACE MODIFICATION OF POLYMERIC BIOMATERIALS WITH POLY(ETHYLENE OXIDE), ALBUMIN, AND HEPARIN FOR REDUCED THROMBOGENICITY
    AMIJI, M
    PARK, K
    [J]. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 1993, 4 (03) : 217 - 234
  • [3] Biodegradation and biocompatibility of PLA and PLGA microspheres
    Anderson, JM
    Shive, MS
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1997, 28 (01) : 5 - 24
  • [4] Rationalizing the design of polymeric biomaterials
    Angelova, N
    Hunkeler, D
    [J]. TRENDS IN BIOTECHNOLOGY, 1999, 17 (10) : 409 - 421
  • [5] Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid polyglycolic acid copolymers
    Athanasiou, KA
    Niederauer, GG
    Agrawal, CM
    [J]. BIOMATERIALS, 1996, 17 (02) : 93 - 102
  • [6] Host response to tissue engineered devices
    Babensee, JE
    Anderson, JM
    McIntire, LV
    Mikos, AG
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1998, 33 (1-2) : 111 - 139
  • [7] Chemical modification of poly(vinyl chloride) resin using poly(ethylene glycol) to improve blood compatibility
    Balakrishnan, B
    Kumar, DS
    Yoshida, Y
    Jayakrishnan, A
    [J]. BIOMATERIALS, 2005, 26 (17) : 3495 - 3502
  • [8] BIOCOMPATIBILITY OF A NEW SEMISOLID BIOERODIBLE POLY(ORTHO ESTER) INTENDED FOR THE OCULAR DELIVERY OF 5-FLUOROURACIL
    BERNATCHEZ, SF
    MERKLI, A
    MINH, TL
    TABATABAY, C
    ANDERSON, JM
    GURNY, R
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1994, 28 (09): : 1037 - 1046
  • [9] BIOTOLERANCE OF A SEMISOLID HYDROPHOBIC BIODEGRADABLE POLY(ORTHO ESTER) FOR CONTROLLED DRUG DELIVERY
    BERNATCHEZ, SF
    MERKLI, A
    TABATABAY, C
    GURNY, R
    ZHAO, QH
    ANDERSON, JM
    HELLER, J
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1993, 27 (05): : 677 - 681
  • [10] NORPLANT - SYSTEMIC IMMUNOLOGICAL COMPLICATIONS - CASE-REPORT
    CAMPBELL, A
    BRAUTBAR, N
    [J]. TOXICOLOGY AND INDUSTRIAL HEALTH, 1995, 11 (01) : 41 - 47